Explore

Rapid Read Rapid Read
AI and Robotics Revolutionize Healthcare Diagnostics and Treatment

AI and Robotics Revolutionize Healthcare Diagnostics and Treatment

Artificial intelligence (AI) and robotics are becoming integral to modern healthcare, transitioning from experimental tools to essential components in patient care. These technologies assist in various stages of healthcare delivery, from early detection and treatment planning to surgical interventions. AI-powered clinical decision support systems are enhancing diagnostic accuracy, particularly in interpreting medical images and laboratory data. Despite their effectiveness, these systems often function as 'black boxes,' which can limit clinician trust. Explainable AI is being developed to address this issue by providing transparency in AI decision-making processes. Additionally, AI is playing a significant role in drug discovery, expediting the development of new treatments by identifying targets and designing molecules. Wearable sensors powered by AI are also extending healthcare monitoring beyond clinical settings, offering continuous health tracking. In surgical settings, robotics are advancing towards g...
Rapid Read Rapid Read
Blood Tests for Alzheimer’s Detection in Down Syndrome Show Promising Results

Blood Tests for Alzheimer’s Detection in Down Syndrome Show Promising Results

A study led by USC researchers has demonstrated the effectiveness of blood tests in detecting Alzheimer’s disease in individuals with Down syndrome. The study evaluated two blood-based biomarkers, Lumipulse G p-tau217/β-Amyloid 1-42 and PrecivityAD2, in 39 participants with Down syndrome. These tests successfully identified abnormal amyloid burden in the brain, offering a less invasive and scalable alternative to traditional methods like brain imaging. This advancement is crucial as people with Down syndrome have a higher incidence of Alzheimer’s, yet are often overlooked in diagnostic advancements.
Trendline Trendline
Nihon Kohden Expands NomadAir System to Dental Sleep Medicine

Nihon Kohden Expands NomadAir System to Dental Sleep Medicine

Nihon Kohden Expands NomadAir System to Dental Sleep Medicine
Rapid Read Rapid Read
USC Study Validates Blood Tests for Alzheimer's Detection in Down Syndrome Population

USC Study Validates Blood Tests for Alzheimer's Detection in Down Syndrome Population

A recent study led by the University of Southern California has validated the use of blood-based biomarkers for detecting Alzheimer's disease in individuals with Down syndrome. The study, published in Communications Medicine, evaluated two specific biomarkers, Lumipulse G p-tau217/β-Amyloid 1-42 and PrecivityAD2, in 39 participants with Down syndrome. These biomarkers were compared against amyloid PET imaging, a standard method for detecting brain amyloid pathology. The results showed that both blood tests reliably identified abnormal amyloid burden in the brain, providing a non-invasive and practical method for early Alzheimer's detection in this high-risk group. The study also established preliminary diagnostic thresholds for Down syndrome, which could aid in clinical decision-making.
Trendline Trendline
Labcorp Expands Genetic Testing with New Health Panel for Disease Prevention

Labcorp Expands Genetic Testing with New Health Panel for Disease Prevention

Labcorp Expands Genetic Testing with New Health Panel for Disease Prevention
Rapid Read Rapid Read
Feinstein Institutes Releases First Comprehensive Vagus Nerve Map, Advancing Bioelectronic Medicine

Feinstein Institutes Releases First Comprehensive Vagus Nerve Map, Advancing Bioelectronic Medicine

The Feinstein Institutes for Medical Research has unveiled the world's first comprehensive anatomical map of the human vagus nerve. This groundbreaking dataset, funded by a $6.7 million NIH grant, provides detailed insights into the nerve's structure and function. The map was developed using advanced imaging techniques and data from 30 human donors. It offers a 3D view of the vagus nerve, which plays a crucial role in regulating automatic bodily functions and immune responses. This resource is expected to accelerate the development of bioelectronic medicine and neuromodulation therapies.
Trendline Trendline
Suki Researchers Call for New Standards in AI Scribe Evaluation

Suki Researchers Call for New Standards in AI Scribe Evaluation

Suki Researchers Call for New Standards in AI Scribe Evaluation
Trendline Trendline
Flourish Health Secures $26 Million to Expand Youth Mental Healthcare

Flourish Health Secures $26 Million to Expand Youth Mental Healthcare

Flourish Health Secures $26 Million to Expand Youth Mental Healthcare
Rapid Read Rapid Read
University of Michigan Offers Hybrid Role for AI Systems Engineer to Enhance Research Infrastructure

University of Michigan Offers Hybrid Role for AI Systems Engineer to Enhance Research Infrastructure

The University of Michigan is seeking an AI Systems Engineer to join its AI & Digital Health Innovation (AI&DHI) team. This role is pivotal in designing, building, and maintaining systems that support AI-driven research and clinical tools across Michigan Medicine. The position is primarily hybrid, allowing for remote work with some onsite opportunities in Ann Arbor. The engineer will be responsible for developing data pipelines, managing containerized applications using Kubernetes, and integrating AI tools with institutional systems. The role requires a strong background in systems development, container orchestration, and AI tool deployment. The position is part of a broader effort by the university to enhance its research capabilities through advanced AI and digital health technologies.
Trendline Trendline
Myriad Genetics Collaborates with AWS to Enhance AI Document Processing

Myriad Genetics Collaborates with AWS to Enhance AI Document Processing

Myriad Genetics Collaborates with AWS to Enhance AI Document Processing
Rapid Read Rapid Read
Telefónica Tech and Harrison.ai Collaborate on AI Tool for Enhanced X-Ray Diagnostics

Telefónica Tech and Harrison.ai Collaborate on AI Tool for Enhanced X-Ray Diagnostics

Telefónica Tech has partnered with Harrison.ai to introduce an AI-powered diagnostic tool designed to assist radiologists in analyzing chest X-rays. This tool, which will be implemented across regional health services in Spain, is capable of identifying up to 124 clinical findings from a single X-ray, including critical indicators for lung cancer. The AI system is intended to support medical staff by providing rapid second opinions, thereby aiding in the early detection and prioritization of urgent cases. The tool is integrated into existing clinical infrastructures, allowing for seamless access through standard web browsers, which can expedite initial triage decisions in emergency and primary care settings.
Rapid Read Rapid Read
Systematic Review Highlights Need for Standardized Endpoints in Alzheimer's Trials

Systematic Review Highlights Need for Standardized Endpoints in Alzheimer's Trials

A systematic review of Alzheimer's clinical trials conducted over the past decade has highlighted significant variability in the endpoints used to measure drug efficacy. The review, which analyzed 238 trials from 2015 to 2025, found that while cognitive performance is the most commonly assessed domain, there is a lack of standardization in outcome measures. This inconsistency complicates the comparison of drug efficacy across studies and poses challenges for regulatory approval. The review calls for the establishment of standardized, consensus-based core outcome sets to improve trial comparability and ensure that clinical benefits translate into real-world improvements for patients.